Select Page

VIZIMPRO® (dacomitinib) tablets, for oral use. Initial U.S. Approval: 2018

VIZIMPRO® (dacomitinib) tablets, for oral use. Initial U.S. Approval: 2018

VIZIMPRO® (dacomitinib) tablets is a prescription medicine. VIZIMPRO® (dacomitinib) tablets is used for metastatic lung cancer (non-small cell lung cancer-NSCLC) treatment.

INDICATIONS AND USAGE
VIZIMPRO is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.
DOSAGE FORMS & STRENGTHS
Tablets: 15 mg, 30 mg, and 45 mg.
Manufactured By:  Pfizer, Inc.
Prescribing Information URL: Click Here

Procedure to buy VIZIMPRO® (dacomitinib) tablets?
To buy VIZIMPRO® (dacomitinib) tablets for injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Dacomitinib, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma (NSCLC). It is a selective and irreversible inhibitor of EGFR.

Dacomitinib was approved for medical use in the United States in September 2018, in Japan in 2019, and in the European Union in 2019, for the treatment of non-small cell lung cancer with epidermal growth factor receptor (EGFR) gene mutation.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

VIZIMPRO® (dacomitinib) tablets in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
VIZIMPRO® (dacomitinib) tablets in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
VIZIMPRO® (dacomitinib) tablets in North America – Mexico.
VIZIMPRO® (dacomitinib) tablets in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
VIZIMPRO® (dacomitinib) tablets in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
VIZIMPRO® (dacomitinib) tablets in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
VIZIMPRO® (dacomitinib) tablets in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
VIZIMPRO® (dacomitinib) tablets in Australia and New Zealand.

For Indian Patient

Ani-Cancer VIZIMPRO® (dacomitinib) tablets are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

VIZIMPRO® (dacomitinib) tablets can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “VIZIMPRO® (dacomitinib) tablets, for oral use. Initial U.S. Approval: 2018”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.